Skip to content
VuFind
English
Deutsch
Español
Français
Italiano
日本語
Nederlands
Português
Português (Brasil)
中文(简体)
中文(繁體)
Türkçe
עברית
Gaeilge
Cymraeg
Ελληνικά
Català
Euskara
Русский
Čeština
Suomi
Svenska
polski
Dansk
slovenščina
اللغة العربية
বাংলা
Galego
Tiếng Việt
Hrvatski
हिंदी
Հայերէն
Українська
Sámegiella
Монгол
Language
All Fields
Title
Author
Subject
Call Number
ISBN/ISSN
Tag
Find
Advanced
The interleukin 21 pathway is...
Cite this
Text this
Email this
Print
Export Record
Export to RefWorks
Export to EndNoteWeb
Export to EndNote
Permanent link
The interleukin 21 pathway is critical for development of pathogenic antibodies in a chronic GVH model of SLE
Bibliographic Details
Main Authors:
Damphousse, C
,
Groves, C
,
Brown, T
,
Lowe, L
,
Nickerson-Nutter, C
,
Collins, M
,
Jr, O
,
Young, D
Format:
Conference item
Published:
2006
Holdings
Description
Similar Items
Staff View
Similar Items
INFLUENCE OF ISOTYPE ON SUPPRESSION OF GVH WITH ANTI-TH-1
by: Thierfelder, S, et al.
Published: (1984)
21 Management of skin involvement in SLE
by: Antonio Guilabert Vidal
Published: (2023-09-01)
Loss of antiphospholipid antibody positivity post-thrombosis in SLE
by: Muznay Khawaja
Published: (2020-10-01)
Migraine in SLE: role of antiphospholipid antibodies and Raynaud’s phenomenon
by: Serena D'Agostini, et al.
Published: (2011-09-01)
Design and Characterization of Novel Antibody-Cytokine Fusion Proteins Based on Interleukin-21
by: Cesare Di Nitto, et al.
Published: (2022-03-01)